Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center

Objectives: Relapsed/refractory acute B-cell lymphoblastic leukemia (R/R B-ALL) often responds poorly to induction chemotherapy. However, recent research has shown a novel and effective drug treatment for R/R B-ALL.Methods: A total of eight patients with R/R B-ALL were enrolled in the study from Nov...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ziyi Hao, Yingying Fei, Juan Chen, Sailan Huang, Li Wang, Youhuan Yu, Meiru Bian, Yejun Si, Xingxia Zhang, Xiaotian Yang, Bing Zhang, Yan Wan, Guoqiang Lin, Yanming Zhang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2024-12-01
Serie:	Hematology
Soggetti:	relapsed/refractory B-ALL venetoclax azacytidine cancer remission
Accesso online:	https://www.tandfonline.com/doi/10.1080/16078454.2024.2344998
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!